A Rational Approach to the Design and Synthesis of a New Bradykinin B1 Receptor Antagonist
Philippe Bedos, Muriel Amblard, Gilles Subra et al. · Journal of Medicinal Chemistry · 2000
We have previously synthesized a potent and selective B(1) bradykinin receptor antagonist, JMV1645 (H-Lys-Arg-Pro-Hyp-Gly-Igl-Ser-D-BT-OH), containing a dipeptide mimetic ((3S)-amino-5-carbonylmethyl-2,3-dihydro-1, 5-benzothiazepin-4(5H)-one (D-BT) moiety) at the C-terminal. Analogues of this potent B(1) bradykinin receptor antagonist in which the central Pro(2)-Hyp(3)-Gly(4)-Igl(5) tetrapeptide has been replaced by constrained N-1-substituted-1,3,8-triazaspiro¿4. 5decan-4-one ring system were synthesized. Among these analogues, compound JMV1640 (1) was found to have an affinity of 24.10 +/- 9.48 nM for the human cloned B(1) receptor. It antagonized the ¿des-Arg(10)-kallidin-induced contraction of the human umbilical vein (pA(2) = 6.1 +/- 0.1). Compound 1 was devoid of agonist activity at the kinin B(1) receptor. Moreover, it did not bind to the human cloned B(2) receptor. Therefore, JMV1640 constitutes a lead compound for the rational search of nonpeptide B(1) receptor analogues based on the BK sequence.
Cited by 25 works. doi:10.1021/jm990962k
Authors
- Philippe Bedos
- Muriel Amblard
- Gilles Subra
- Pierre Dodey
- Jean‐Michel Luccarini
- Jean‐Luc Paquet
- Didier Pruneau
- André Aumelas
- Jean Martínez
References
- Natural abundance nitrogen-15 NMR by enhanced heteronuclear spectroscopy
- Improved spectral resolution in COSY 1H NMR spectra of proteins via double quantum filtering
- N-methoxy-n-methylamides as effective acylating agents
- The Preparation of Merrifield‐Resins Through Total Esterification With Cesium Salts
- Kinin B1 receptors: a review
- Expression cloning of a human B1 bradykinin receptor.
- Human carboxypeptidase M
- Antinociceptive activity of the bradykinin B1 and B2 receptor antagonists, des-Arg9, [Leu8]-BK and HOE 140, in two models of persistent hyperalgesia in the rat
- A new class of bradykinin antagonists: synthesis and in vitro activity of bissuccinimidoalkane peptide dimers
- Design of potent non-peptide competitive antagonists of the human bradykinin B2 receptor